| RS2494271127 |
SOX6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2494271432 |
PIK3C2A
|
Health Risk |
Pathogenic |
— |
| RS2494286656 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS2494291485 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, BETA-PLUS-THALASSEMIA |
| RS2494292030 |
HBB
|
Health Risk |
Pathogenic |
Dominant beta-thalassemia, Dominant beta-thalassemia |
| RS2494292050 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS2494292407 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS2494292446 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS2494295133 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Malaria, susceptibility to |
| RS2494295306 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS2494296091 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS2494296171 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS2494296194 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS2494297067 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS2494297176 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS2494297181 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS2494305988 |
ANO5
|
Health Risk |
Likely pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2494306436 |
ANO5
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494318394 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494319408 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2494319481 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494324095 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494324455 |
ANO5
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494325585 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Atrial fibrillation, familial |
| RS2494328715 |
ENTPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2494334628 |
HBG2
|
Health Risk |
Pathogenic |
Cyanosis, transient neonatal |
| RS2494336043 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494337734 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494339264 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2494343833 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494344104 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494344217 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494344629 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494352625 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS2494356918 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494357398 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2494357401 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494359243 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2494359300 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494361871 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494362254 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494362658 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Frasier syndrome, Wilms tumor 1 |
| RS2494363622 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2494369582 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2494369768 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS2494369791 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494369913 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494370978 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS2494374376 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494374535 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494377215 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494377719 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494378027 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494378255 |
DEAF1
|
Health Risk |
Likely pathogenic |
— |
| RS2494378551 |
ODAD2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS2494378579 |
DEAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability-epilepsy-extrapyramidal syndrome, Intellectual disability-epilepsy-extrapyramidal syndrome |
| RS2494378840 |
ODAD2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS2494379304 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS2494379970 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494379988 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494380076 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494380120 |
CDKN1C
|
Health Risk |
Likely pathogenic |
CDKN1C-related disorder, CDKN1C-related disorder |
| RS2494380150 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494380217 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494380322 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494383793 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494383846 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494384051 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494384315 |
CDH23
|
Health Risk |
Pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494384452 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494384538 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494384555 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494384846 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494384859 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494385188 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494385326 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494385418 |
CDH23
|
Health Risk |
Pathogenic |
Sensorineural hearing loss disorder, Sensorineural hearing loss disorder |
| RS2494385585 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494385765 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494385784 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494385885 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494385919 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2494386440 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2494386494 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494386556 |
ANO5
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 3, Miyoshi muscular dystrophy 3 |
| RS2494386964 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494387330 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494388249 |
CDKN1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494388585 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494388964 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494389055 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494389104 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494389952 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494389957 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494390803 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494390854 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494390913 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494391145 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2494395195 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494395295 |
CDH23
|
Health Risk |
Pathogenic |
— |